• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药效团模型作为发现新型非竞争性AMPA受体拮抗剂的有效工具。

Pharmacophore modeling as an efficient tool in the discovery of novel noncompetitive AMPA receptor antagonists.

作者信息

Barreca Maria Letizia, Gitto Rosaria, Quartarone Silvana, De Luca Laura, De Sarro Giovambattista, Chimirri Alba

机构信息

Dipartimento Farmaco-Chimico, Università di Messina, Viale Annunziata, 98168 Messina, Italy.

出版信息

J Chem Inf Comput Sci. 2003 Mar-Apr;43(2):651-5. doi: 10.1021/ci025625q.

DOI:10.1021/ci025625q
PMID:12653534
Abstract

A three-dimensional pharmacophore model for the binding of noncompetitive AMPA receptor antagonists was developed in order to map common structural features of highly active compounds. This hypothesis, which consists of two hydrophobic regions, one hydrogen bond acceptor and one aromatic region, was successfully used as framework for the design of a new class of allosteric modulators containing a tetrahydroisoquinoline skeleton and for in silico screening. The promising biological results suggested that the identified molecules might be useful "lead compounds" for future drug development.

摘要

为了描绘高活性化合物的共同结构特征,开发了一种用于非竞争性AMPA受体拮抗剂结合的三维药效团模型。该假说由两个疏水区域、一个氢键受体和一个芳香区域组成,已成功用作设计一类含有四氢异喹啉骨架的新型变构调节剂以及计算机筛选的框架。有前景的生物学结果表明,所鉴定的分子可能是未来药物开发中有用的“先导化合物”。

相似文献

1
Pharmacophore modeling as an efficient tool in the discovery of novel noncompetitive AMPA receptor antagonists.药效团模型作为发现新型非竞争性AMPA受体拮抗剂的有效工具。
J Chem Inf Comput Sci. 2003 Mar-Apr;43(2):651-5. doi: 10.1021/ci025625q.
2
Discovery of a novel and highly potent noncompetitive AMPA receptor antagonist.一种新型高效非竞争性AMPA受体拮抗剂的发现。
J Med Chem. 2003 Jan 2;46(1):197-200. doi: 10.1021/jm0210008.
3
3D-QSAR studies for the binding affinity toward (R, S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)-propionic acid receptor.针对(R,S)-2-氨基-3-(3-羟基-5-甲基异恶唑-4-基)-丙酸受体结合亲和力的3D-QSAR研究。
Acta Pharm. 2008 Sep;58(3):335-45. doi: 10.2478/v10007-008-0020-5.
4
QSAR study of anticonvulsant negative allosteric modulators of the AMPA receptor.
J Med Chem. 2004 Mar 25;47(7):1860-3. doi: 10.1021/jm0310838.
5
Synthesis and anticonvulsant evaluation of N-substituted isoquinoline AMPA receptor antagonists.N-取代异喹啉AMPA受体拮抗剂的合成与抗惊厥活性评价
Bioorg Med Chem. 2008 Mar 1;16(5):2379-84. doi: 10.1016/j.bmc.2007.11.071. Epub 2007 Nov 29.
6
Design and synthesis of novel quinoxaline-2,3-dione AMPA/GlyN receptor antagonists: amino acid derivatives.新型喹喔啉-2,3-二酮AMPA/甘氨酸N受体拮抗剂的设计与合成:氨基酸衍生物
J Med Chem. 1999 Jun 17;42(12):2266-71. doi: 10.1021/jm980455n.
7
Synthesis and pharmacological studies at the Gly/NMDA, AMPA and Kainate receptors of new oxazolo[4,5-c]quinolin-4-one derivatives bearing different substituents at position-2 and on the fused benzo ring.新型恶唑并[4,5-c]喹啉-4-酮衍生物在2位和稠合苯环上带有不同取代基时,对甘氨酸/N-甲基-D-天冬氨酸受体、α-氨基-3-羟基-5-甲基-4-异恶唑丙酸受体和海人藻酸受体的合成及药理研究。
Eur J Med Chem. 2005 Sep;40(9):897-907. doi: 10.1016/j.ejmech.2005.03.017.
8
Novel potent anticonvulsant agent containing a tetrahydroisoquinoline skeleton.含有四氢异喹啉骨架的新型强效抗惊厥剂。
J Med Chem. 2006 Sep 7;49(18):5618-22. doi: 10.1021/jm060411b.
9
First pharmacophoric hypothesis for T-type calcium channel blockers.T型钙通道阻滞剂的首个药效团假说。
Bioorg Med Chem. 2004 Apr 1;12(7):1605-11. doi: 10.1016/j.bmc.2004.01.034.
10
New 7,8-ethylenedioxy-2,3-benzodiazepines as noncompetitive AMPA receptor antagonists.新型7,8-亚乙基二氧基-2,3-苯并二氮杂䓬类化合物作为非竞争性AMPA受体拮抗剂。
Bioorg Med Chem Lett. 2006 Jan 1;16(1):167-70. doi: 10.1016/j.bmcl.2005.09.029. Epub 2005 Oct 10.

引用本文的文献

1
The Current State and Future Outlook of PET Tracers for AMPA Receptors.用于AMPA受体的正电子发射断层显像(PET)示踪剂的现状与未来展望
Neurosci Bull. 2025 Mar;41(3):531-535. doi: 10.1007/s12264-024-01332-w. Epub 2024 Dec 11.
2
In Silico Studies in Drug Research Against Neurodegenerative Diseases.计算机药物研究在神经退行性疾病防治中的应用
Curr Neuropharmacol. 2018;16(6):664-725. doi: 10.2174/1570159X15666170823095628.
3
Radiosynthesis and preliminary PET evaluation of (18)F-labeled 2-(1-(3-fluorophenyl)-2-oxo-5-(pyrimidin-2-yl)-1,2-dihydropyridin-3-yl)benzonitrile for imaging AMPA receptors.
用于成像AMPA受体的(18)F标记的2-(1-(3-氟苯基)-2-氧代-5-(嘧啶-2-基)-1,2-二氢吡啶-3-基)苯甲腈的放射性合成及初步PET评估
Bioorg Med Chem Lett. 2016 Oct 1;26(19):4857-4860. doi: 10.1016/j.bmcl.2016.07.078. Epub 2016 Aug 9.
4
In silico work flow for scaffold hopping in Leishmania.利什曼原虫中基于计算机的骨架跃迁工作流程。
BMC Res Notes. 2014 Nov 17;7:802. doi: 10.1186/1756-0500-7-802.
5
In silico pharmacology for drug discovery: applications to targets and beyond.用于药物发现的计算机模拟药理学:对靶点及其他方面的应用
Br J Pharmacol. 2007 Sep;152(1):21-37. doi: 10.1038/sj.bjp.0707306. Epub 2007 Jun 4.
6
Characterization of beta3-adrenergic receptor: determination of pharmacophore and 3D QSAR model for beta3 adrenergic receptor agonism.β3肾上腺素能受体的表征:β3肾上腺素能受体激动作用的药效团确定及三维定量构效关系模型
J Comput Aided Mol Des. 2005 Feb;19(2):93-110. doi: 10.1007/s10822-005-1558-7.